Serum Concanavalin-A Binding in Rheumatoid Arthritis
Overview
Authors
Affiliations
A nephelometric assay of concanavalin-A binding of serum acute phase proteins (con-A binding) has been used in cross-sectional and sequential studies of disease activity in rheumatoid arthritis (RA). Con-A binding correlated well with blood viscosity, C-reactive protein, and other individual acute phase reactants in patients with active RA. Twenty-four patients were treated for 6 months with D-penicillamine and assessed clinically and seriologically. Clinical improvement was accompanied by significant falls in both C-reactive protein and con-A binding, although the serological changes did not always occur in parallel in individual patients. The advantages of this simple, cheap assay of acute phase proteins are discussed.
Gaston J, Rickinson A, Yao Q, Epstein M Ann Rheum Dis. 1986; 45(11):932-6.
PMID: 2878645 PMC: 1002022. DOI: 10.1136/ard.45.11.932.